Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: A 2-year, open-label extension study

International Journal of Clinical Practice

Volumn 62, Issue 10, 2008, Pages 1499-1510

  Lutjohann D ^a   Von Bergmann, K ^a   Sirah, W ^b   Macdonell, G ^b   Johnson Levonas, A O ^b   Shah, A ^b   Lin, J ^b   Sapre, A ^b   Musliner, T ^b  

^a UNIVERSITY OF BONN   (Germany)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPESTEROL; EZETIMIBE; LATHOSTEROL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HOMOZYGOSITY; HUMAN; LONG TERM CARE; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SITOSTEROLEMIA; UPPER RESPIRATORY TRACT INFECTION;

ACHILLES TENDON; ADOLESCENT; ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHILD; DOUBLE-BLIND METHOD; FEMALE; HOMOZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; SITOSTEROLS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51349104822     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01841.x     Document Type: Article

References (34)

1. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev 2002 20 : 255 70.
2. Lee MH, Lu K, Hazard S et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001 27 : 79 83.
3. Patel SB, Salen G, Hidaka H et al. Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest 1998 102 : 1041 4.
4. Lu K, Lee MH, Hazard S et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001 69 : 278 90.
5. Lee MH, Lu K, Patel SB. Genetic basis of sitosterolemia. Curr Opin Lipidol 2001 12 : 141 9.
6. Berge KE, Tian H, Graf GA et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000 290 : 1771 5.
7. Salen G, Horak I, Rothkopf M et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 1985 26 : 1126 33.
8. Hidaka H, Yasuda H, Kobayashi M et al. Familial spinal xanthomatosis with sitosterolemia. Intern Med 1992 31 : 1038 42.
9. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974 53 : 1033 43.
10. Miettinen TA. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 1980 10 : 27 35.
11. Shulman RS, Bhattacharyya AK, Connor WE, Fredrickson DS. Beta-sitosterolemia and xanthomatosis. N Engl J Med 1976 294 : 482 3.
12. Kolovou G, Voudris V, Drogari E, Palatianos G, Cokkinos DV. Coronary bypass grafts in a young girl with sitosterolemia. Eur Heart J 1996 17 : 965 6.
13. Salen G, Shefer S, Nguyen L, Ness GC, Tint GS, Shore V. Sitosterolemia. J Lipid Res 1992 33 : 945 55.
14. Belamarich PF, Deckelbaum RJ, Starc TJ, Dobrin BE, Tint GS, Salen G. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics 1990 86 : 977 81.
15. Salen G, von Bergmann K, Lutjohann D et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004 109 : 966 71.
16. Sudhop T, Lutjohann D, von Bergmann K. Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol Ther 2005 105 : 333 41.
17. von Bergmann K, Sudhop T, Lutjohann D. Cholesterol and plant sterol absorption: recent insights. Am J Cardiol 2005 96 : 10D 4D.
18. Sudhop T, Lutjohann D, Kodal A et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002 106 : 1943 8.
19. Davis HR Jr., Zhu LJ, Hoos LM et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004 279 : 33586 92.
20. Altmann SW, Davis HR Jr., Zhu LJ et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004 303 : 1201 4.
21. Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 2005 44 : 467 94.
22. Connor WE, Lin DS, Pappu AS, Frohlich J, Gerhard G. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues. Lipids 2005 40 : 919 23.
23. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978 19 : 65 76.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
25. Lutjohann D, Bjorkhem I, Beil UF, von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res 1995 36 : 1763 73.
26. Moghadasian MH, Frohlich JJ, Scudamore CH. Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J Clin Pathol 2002 55 : 859 61.
27. Lutjohann D, Brzezinka A, Barth E et al. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res 2002 43 : 1078 85.
28. Tolman KG. Defining patient risks from expanded preventive therapies. Am J Cardiol 2000 85 : 15E 9E.
29. Ucar M, Mjorndal T, Dahlqvist R. HMG-CoA reductase inhibitors and myotoxicity. Drug Saf 2000 22 : 441 57.
30. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990 131 : 20 31.
31. Jakulj L, Trip MD, Sudhop T, von Bergmann K, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005 46 : 2692 8.
32. Honda A, Salen G, Nguyen LB, Tint GS, Batta AK, Shefer S. Down-regulation of cholesterol biosynthesis in sitosterolemia: diminished activities of acetoacetyl-CoA thiolase, 3-hydroxy-3-methylglutaryl-CoA synthase, reductase, squalene synthase, and 7-dehydrocholesterol delta7-reductase in liver and mononuclear leukocytes. J Lipid Res 1998 39 : 44 50.
33. Nguyen LB, Salen G, Shefer S, Tint GS, Shore V, Ness GC. Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function. Metabolism 1990 39 : 436 43.
34. Salen G, Starc T, Sisk CM, Patel SB. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis. Gastroenterology 2006 130 : 1853 7.